ICSTI Statement on Nanotechnology - Forfás

More documents

Recommendations

Info

<strong>ICSTI</strong> MEMBERSHIP Dr. Edward M. Walsh (Chairman) President Emeritus University of Limerick Dr. Leonora Bishop Business Consultant Ms. Mary Burke Managing Director BioClin Research Laboratories Mr. Ian Cahill Chairman LM Ericsson Ltd. & Director, National Institute of Technology Management Ms. Marion Coy Director Galway-Mayo Institute of Technology Mr. Martin Cronin Chief Executive Forfás Ms. Mary Cryan Director of Technology Prospectus Strategy Consultants Dr. Ann Cullinane Head, Virology Unit Irish Equine Foundation Ltd. Prof. Donald Fitzmaurice Solar Technology Group Chemistry Dept., National University of Ireland, Dublin Dr. Peter Heffernan Chief Executive Marine Institute Mr. Paul Holden Managing Director Rédacteurs Ltd. Dr. Mike Hopkins Physicist Scientist Plasma Research Laboratory, Dublin City University Dr. Brendan Hughes Director of Drug Development Wyeth Medica Ireland Development Facility Ms. Josephine Lynch Secretary to Council Forfás Prof. Tom McCarthy Dean of the Business School Dublin City University Prof. Anita R. Maguire Dept. of Chemistry National University of Ireland, Cork Dr. David Melody Formerly Vice President for R&D (Formerly) Loctite (Ireland) Ltd. Dr. Pierre Meulien Chief Executive Dublin Molecular Medicine Centre 121
122 Dr. Pat Morgan Dean, Faculty of Science National University of Ireland, Galway Dr. Mike Peirce Chairman Mentec Ltd. Dr. Ena Prosser Director BioResearch Directorate, Enterprise Ireland Prof. William J Reville Biochemistry Dept. National University of Ireland, Cork Prof. James A. Slevin Science Secretary Royal Irish Academy Dr. Don Thornhill Chairman Higher Education Authority Dr. Ena Walsh Head of Operations and Business Development Centre for Human Proteomics, Royal College of Surgeons in Ireland
Page 1 and 2:
I C STI I R E L A N D Irish Council
Page 3 and 4:
FUNCTIONS OF THE IRISH COUNCIL FOR
Page 5 and 6:
2 CONTENTS 6.5 Healthcare - Medical
Page 7 and 8:
4 1.0 EXECUTIVE SUMMARY Knowledge e
Page 9 and 10:
6 Nanotechnology - National Roadmap
Page 11 and 12:
8 Assuming that the recommendations
Page 13 and 14:
10 A significant increase in the nu
Page 15 and 16:
12 2.0 INTRODUCTION 2.1 Background
Page 17 and 18:
14 2.5 Acknowledgements The Council
Page 19 and 20:
16 and lowered as it scans across t
Page 21 and 22:
18 Figure 3.3: Nanocrystals of the
Page 23 and 24:
20 4.0 ROADMAP 4.1 Background The n
Page 25 and 26:
22 4.4 Nanotechnology Enabled Produ
Page 27 and 28:
24 5.0 OPPORTUNITY 5.1 Background I
Page 29 and 30:
26 5.3 Improved Products and Proces
Page 31 and 32:
28 Figure 5.2: The launch of vehicl
Page 33 and 34:
30 An example of a multinational co
Page 35 and 36:
32 5.6 Conclusions Based on the abo
Page 37 and 38:
34 The above work for each sector w
Page 39 and 40:
36 Year of Production 2002 2004 200
Page 41 and 42:
38 Ireland should examine its curre
Page 43 and 44:
40 At the present time the photonic
Page 45 and 46:
42 6.4.2 Sector Roadmap From a tech
Page 47 and 48:
44 The growth of the medical device
Page 49 and 50:
46 Table 6.4: Challenges facing the
Page 51 and 52:
48 STAGE ONE: 1980 - 2000 STAGE TWO
Page 53 and 54:
50 it is possible that there will b
Page 55 and 56:
52 6.7.3 Intersection with Nanotech
Page 57 and 58:
54 6.8 Construction Sector 6.8.1 Se
Page 59 and 60:
56 More importantly, nanotechnology
Page 61 and 62:
58 7.0 CAPABILITY 7.1 Background Th
Page 63 and 64:
60 Higher Education Authority; thro
Page 65 and 66:
62 Enterprise Ireland is seeking to
Page 67 and 68:
64 Elan Corporation develops and ma
Page 69 and 70:
66 There are at least six establish
Page 71 and 72:
68 In respect of the second issue,
Page 73 and 74: 70 9.0 NATIONAL NANOTECHNOLOGY FORU
Page 75 and 76: 72 9.3 Conclusions The immediate es
Page 77 and 78: 74 The co-ordination of the funding
Page 79 and 80: 76 10.4 Conclusions The above strat
Page 81 and 82: 78 APPENDIX II Appendix II: Task Fo
Page 83 and 84: 80 Wednesday, 5th March 2003, Gover
Page 85 and 86: 82 Europe - Commission Nanotechnolo
Page 87 and 88: 84 Another important aspect of fund
Page 89 and 90: 86 Enterprise Ireland has already d
Page 91 and 92: 88 2. What is Nanotechnology? Nanot
Page 93 and 94: 90 For example the application of n
Page 95 and 96: 92 3.1.1 Electronics The electronic
Page 97 and 98: 94 3.2. Market development timescal
Page 99 and 100: 96 There are two start-up nanotechn
Page 101 and 102: 98 4.3 Established EI Clients A num
Page 103 and 104: 100 6. Primary targets for the deve
Page 105 and 106: 102 Objective 3. Increase the numbe
Page 107 and 108: 104 Objective 7. Assist researchers
Page 109 and 110: 106 Potential industrial adopters n
Page 111 and 112: 108 Section 2 - National and Intern
Page 113 and 114: 110 ii. Technology Development Rese
Page 115 and 116: 112 UCD Prof. Donald 961,000 Using
Page 117 and 118: 114 5. European Union Funding via F
Page 119 and 120: 116 UCD HPMD-CT-2000-00014 0.45 Cha
Page 121 and 122: 118 Communications Communications i
Page 123: 120 (b) SMEs that are inventors of
Page 127 and 128: 124 A Partnership Approach to Resea
Page 129: July 2004
show all

ICSTI Statement on Nanotechnology - Forfás

Create successful ePaper yourself

Delete template?

Save as template?